Related Experiment Videos
[Cryptococcosis]
1Unité de mycologie Centre national de référence des mycoses humaines et des antifongiques Institut Pasteur 75724 Paris 15. dromer@pasteur.fr
Abstract:
Cryptococcus neoformans, an encapsulated yeast is responsible for life-threatening infection in patients with cellular immune defect especially those with AIDS. The most frequent presentation of cryptococcosis is a disseminated meningoencephalitis without acute onset. The diagnosis is based on direct examination with India ink staining, detection of soluble capsular polysaccharide in body fluids, culture of the micro-organism or histology. Looking for other localisations and for factors of poor prognosis is mandatory before selecting the right treatment regimen. In case of meningitis, one should prefer a combination of amphotericin B and 5 fluorocytosin, followed by a triazole, usually fluconazole until sterilisation of all infected sites is achieved or even for life-time maintenance therapy in case of sustained immune defect.
Insights
Cryptococcus neoformans causes severe infections, particularly meningoencephalitis, in immunocompromised individuals like those with AIDS. Early diagnosis and targeted antifungal therapy, including amphotericin B and fluconazole, are crucial for managing this opportunistic fungal infection.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Immunology
Context:
- Cryptococcus neoformans is an encapsulated yeast causing life-threatening infections.
- Patients with compromised cellular immunity, especially those with Acquired Immunodeficiency Syndrome (AIDS), are at high risk.
- Disseminated meningoencephalitis is the most common presentation of cryptococcosis, often without acute onset.
Purpose:
- To outline diagnostic methods for cryptococcosis.
- To emphasize the importance of identifying secondary infection sites and prognostic factors.
- To guide appropriate treatment strategies for cryptococcal infections.
Summary:
- Diagnosis involves India ink staining, polysaccharide antigen detection, culture, and histology.
- Prognostic factors and additional infection sites must be assessed before treatment.
- Meningitis treatment requires amphotericin B and 5-fluorocytosine, followed by fluconazole, potentially for lifelong maintenance in immune-deficient patients.
Impact:
- Improved diagnostic accuracy for cryptococcosis.
- Optimized treatment selection based on clinical presentation and patient factors.
- Enhanced patient outcomes through effective and prolonged antifungal therapy, reducing mortality and morbidity.